Cervical cancer is a type of cancer that affects the cells of the cervix, the lower part of the uterus that connects to the vagina. It is the fourth most common cancer in women worldwide, and is caused by the human papillomavirus (HPV). Treatment for cervical cancer typically involves surgery, radiation therapy, chemotherapy, and targeted therapy. The cervical cancer market is a subset of the larger oncology market, which is composed of drugs, diagnostics, and services used to treat cancer. The cervical cancer market is expected to grow due to the increasing prevalence of HPV, the development of new treatments, and the increasing availability of healthcare services. Some companies in the cervical cancer market include Merck, Bristol-Myers Squibb, AstraZeneca, Roche, and Novartis. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
